ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Silybin protects against ethanol-induced acute gastric ulcer in rats with PI3K/AKT-associated phosphorylation changes.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine learning-based multi-omic analysis identifies CEP55, DLGAP5, and EZH2 as regulated cell death biomarkers linked to immunotherapy resistance in hepatocellular carcinoma.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study evaluated the effects of silybin in a rat model of ethanol-induced acute gastric ulcer (AGU) using network pharmacology-guided pathway prioritization, molecular docking, and in vivo validation. Network pharmacology identified 48 computational candidate targets. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment mapped these targets to 20 pathways, and PI3K/AKT signaling was selected for experimental assessment. Docking analysis indicated that silybin could be accommodated in the selected PI3K and AKT binding pockets. In rats, oral silybin pretreatment reduced macroscopic ulceration and attenuated histological and ultrastructural injury after ethanol challenge. Silybin-treated rats also showed higher VEGF expression, lower iNOS expression, and increased p-PI3K/PI3K and p-AKT/AKT ratios. These results identify PI3K/AKT phosphorylation as a pathway-associated readout accompanying silybin-mediated gastroprotection.
Indexed as
Identifiers
42405960What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.